Constarium
← Search

Data · study · 2026

Tamoxifen Targets Wisp2 to Impair Subcutaneous Adipose Progenitor Self-Renewal and Adipogenic Differentiation

Listed in NCBI GEO

Prolonged tamoxifen treatment for estrogen receptor positive breast cancer disrupts estrogen receptor signaling in subcutaneous adipocytes and downregulates Wnt1-inducible signaling pathway protein 2 (Wisp2/Ccn5), a key regulator of progenitor cell maintenance.

Description

The resulting reduction in cell proliferation, impaired self renewal of progenitors, and reduced adipogenic differentiation by tamoxifen prevents healthy adipose tissue expansion.

This study reveals a molecular mechanism for the effects of tamoxifen on adipocyte precursors. To evaluate and compare changes in gene expression profiles, we performed global transcriptomic and pathway analyses following treatment of cells with estradiol or 4OH-tamoxifen, or in cells with or without Wisp2.

Links

Where it is published

Documentation and papers

Topics

From keywords
Life Sciences
Inferred from text
Cancer 75%
Provenance · 1 source records, 8 field assertions
SourceKeyLast seenRaw
NCBI GEOGSE3185537 d agoJSON v1
FieldAssertionExtractorEvidence
access_levelsource · NCBI GEOconnector:ncbi_geo@1.0.0
concepts[disease].local:disease:cancerenrichment · NCBI GEOkeyword-concept-rules@1.0.0title+description (75%)
concepts[field].local:field:life-sciencesmapping · NCBI GEOconnector:ncbi_geo@1.0.0
concepts[method].geo_series_type:expression-profiling-by-arraysource · NCBI GEOconnector:ncbi_geo@1.0.0/gdstype
concepts[organism].NCBITaxon:10090source · NCBI GEOconnector:ncbi_geo@1.0.0/taxon
descriptionsource · NCBI GEOconnector:ncbi_geo@1.0.0/summary
publication_datesource · NCBI GEOconnector:ncbi_geo@1.0.0
titlesource · NCBI GEOconnector:ncbi_geo@1.0.0/title